Israeli Defence Minister Naftali Bennett on Monday said he witnessed a "significant breakthrough" by the country's biological research institute in developing an antibody to COVID-19 infection.
Bennett visited the labs of the Israel Institute for Biological Research (IIBR), a secretive unit that works under the Prime Minister's Office, in Ness Ziona and was briefed by the research team, who revealed that the development phase of COVID-19 antibody or passive vaccine that attacks the virus and neutralizes it in the body has been complete, his office said in a statement cited by The Jerusalem Post.
IIBR is now working to patent its antibody and secure a contract for its commercial development. All legal procedures will be coordinated with the Defence Ministry.
Israeli Defence Minister Naftali Bennett on Monday said he witnessed a "significant breakthrough" by the country's biological research institute in developing an antibody to COVID-19 infection.
Bennett visited the labs of the Israel Institute for Biological Research (IIBR), a secretive unit that works under the Prime Minister's Office, in Ness Ziona and was briefed by the research team, who revealed that the development phase of COVID-19 antibody or passive vaccine that attacks the virus and neutralizes it in the body has been complete, his office said in a statement cited by The Jerusalem Post.
IIBR is now working to patent its antibody and secure a contract for its commercial development. All legal procedures will be coordinated with the Defence Ministry.
45.jpeg)
116.jpeg)
149.jpeg)
69.jpeg)
97.jpeg)
